Testing for all lung cancer mutations at once found cost effective-study
May 16, 2018 at 17:00 PM EDT
CHICAGO, May 16 (Reuters) - Testing advanced lung cancer patients for all of the possible genetic mutations that could be driving their cancer at once is more cost effective than testing for one or a limited number of genes at a time, U.S. researchers reported on Wednesday.
